← Pharmacy curriculum
Module 17010 lessonsRxPrep 2023 Chapter 23, reconciled with CDC STI treatment guidance, CDC 2024 laboratory recommendations, current pregnancy and congenital syphilis guidance, and current product-supply safety notices

Syphilis

Recognize a changing systemic infection, reconcile both serologic test families, stage disease, deliver the exact penicillin regimen, protect vision, hearing, brain, and pregnancy, and close the transmission system.

01

Explain T. pallidum invasion, dissemination, latency, and late organ injury.

02

Recognize primary, secondary, latent, tertiary, neurologic, ocular, and auditory presentations.

03

Interpret traditional and reverse serologic algorithms using both test families.

04

Treat primary, secondary, and early latent disease with the correct benzathine penicillin product.

05

Treat late latent and unknown-duration disease with a complete weekly three-dose sequence.

06

Evaluate and treat neurosyphilis, ocular syphilis, and otosyphilis without delaying organ protection.

07

Screen and treat pregnancy to prevent congenital syphilis using penicillin only.

08

Prevent Bicillin product, route, interval, allergy, and Jarisch-Herxheimer errors.

09

Interpret fourfold nontreponemal titer change at stage-specific follow-up intervals.

10

Manage partners, HIV testing and PrEP, reporting, and reinfection prevention.

170.01

Follow a Systemic Infection Through Time

T. pallidum changes its visible phenotype while dissemination and organ invasion continue. Stage is a clinical and temporal model that determines treatment and follow-up.

What to learn
  • Spirochete
  • Chancre
  • Dissemination
  • Latency
  • Tertiary disease
Clinical pathwayFollow the organism through time
01InoculationDefine the state

Connect stage, serology, organ involvement, pregnancy, treatment history, and exposure.

02DisseminationChoose the intervention

Connect stage, serology, organ involvement, pregnancy, treatment history, and exposure.

03LatencyCheck the boundary

Connect stage, serology, organ involvement, pregnancy, treatment history, and exposure.

04SequelaeOwn the next decision

Connect stage, serology, organ involvement, pregnancy, treatment history, and exposure.

Start at inoculation

T. pallidum crosses skin or mucosa and classically causes a painless chancre, but primary lesions can be multiple, painful, or atypical.

Recognize dissemination

Secondary disease can cause diffuse rash including palms and soles, mucous patches, condyloma lata, lymphadenopathy, fever, liver or kidney findings, and neurologic, ocular, or auditory disease.

Define latency carefully

Latent syphilis has reactive serology without clinical primary, secondary, or tertiary findings. A complete examination is required before using the label.

Keep late injury visible

Untreated disease can later produce cardiovascular syphilis, gummatous lesions, tabes dorsalis, general paresis, or other neurologic injury.

0 of 1 answered
01Which feature excludes syphilis least reliably?
Answer every question to submit.
170.02

Make Two Serologic Test Families Tell One Story

No single reactive serologic result distinguishes untreated infection, treated infection, early seroconversion, or false positivity. Algorithms combine complementary biology.

What to learn
  • RPR
  • VDRL
  • EIA or CIA
  • TPPA
  • Endpoint titer
Clinical pathwayMake two test families agree
01ScreenDefine the state

Connect stage, serology, organ involvement, pregnancy, treatment history, and exposure.

02TiterChoose the intervention

Connect stage, serology, organ involvement, pregnancy, treatment history, and exposure.

03ConfirmCheck the boundary

Connect stage, serology, organ involvement, pregnancy, treatment history, and exposure.

04StageOwn the next decision

Connect stage, serology, organ involvement, pregnancy, treatment history, and exposure.

Use the traditional sequence

A reactive RPR or VDRL is quantified and confirmed with a treponemal test. Nontreponemal assays can have biologic false positives and a prozone effect.

Use the reverse sequence

A reactive treponemal EIA or CIA is followed by quantitative RPR or VDRL. If nonreactive, adjudicate with a second treponemal test, preferably TPPA.

Track with one assay type

RPR and VDRL titers are not interchangeable. Follow the same nontreponemal method and report the endpoint titer.

Do not monitor with treponemal tests

Treponemal antibodies usually persist for life. They establish exposure but generally do not demonstrate cure.

0 of 1 answered
01What follows a reactive EIA and nonreactive RPR in the reverse algorithm?
Answer every question to submit.
170.03

Treat Infectious Early Disease With One Correct Dose

Primary, secondary, and early latent disease share a stage-appropriate long-acting penicillin regimen, but organ involvement and pregnancy create separate pathways.

What to learn
  • Primary
  • Secondary
  • Early latent
  • Benzathine penicillin
  • HIV
Clinical pathwayTreat infectious early disease
01PrimaryDefine the state

Connect stage, serology, organ involvement, pregnancy, treatment history, and exposure.

02SecondaryChoose the intervention

Connect stage, serology, organ involvement, pregnancy, treatment history, and exposure.

03PenicillinCheck the boundary

Connect stage, serology, organ involvement, pregnancy, treatment history, and exposure.

04FollowOwn the next decision

Connect stage, serology, organ involvement, pregnancy, treatment history, and exposure.

Use the recommended adult regimen

Give benzathine penicillin G 2.4 million units IM once for uncomplicated primary, secondary, or early latent syphilis.

Do not add routine doses

Additional benzathine penicillin doses do not improve uncomplicated early-syphilis efficacy in nonpregnant adults, including people with HIV.

Use alternatives narrowly

For a nonpregnant patient with a true allergy and reliable follow-up, doxycycline 100 mg orally twice daily for 14 days can be used. Azithromycin should not be used because of resistance and failures.

Close the visit

Test for HIV, offer PrEP when appropriate, examine for organ involvement, report to public health, manage partners, counsel about the Jarisch-Herxheimer reaction, and schedule titers.

0 of 1 answered
01What is recommended for uncomplicated primary syphilis in a nonpregnant adult?
Answer every question to submit.
170.04

Prove Recency or Treat the Unknown Duration

Early latency requires evidence of acquisition within the previous year. Titer magnitude alone cannot prove it.

What to learn
  • Seroconversion
  • Fourfold rise
  • Recent symptoms
  • Documented partner
  • Unknown duration
Clinical pathwayProve the duration
01Early latentDefine the state

Connect stage, serology, organ involvement, pregnancy, treatment history, and exposure.

02Late latentChoose the intervention

Connect stage, serology, organ involvement, pregnancy, treatment history, and exposure.

03UnknownCheck the boundary

Connect stage, serology, organ involvement, pregnancy, treatment history, and exposure.

04ScheduleOwn the next decision

Connect stage, serology, organ involvement, pregnancy, treatment history, and exposure.

Define early latent evidence

Use documented seroconversion, a sustained fourfold titer rise, unequivocal primary or secondary symptoms, a partner with documented early syphilis, or an exposure window confined to the prior 12 months.

Do not stage from titer alone

Nontreponemal titers tend to be higher early but overlap widely. A high titer cannot prove early latent disease.

Treat late or unknown duration

Give benzathine penicillin G 2.4 million units IM weekly for three doses, totaling 7.2 million units.

Manage intervals

For nonpregnant adults, 7 to 9 days is preferred and 10 to 14 days may be acceptable before restarting. Pregnancy has a stricter rule and requires restart when delay exceeds 9 days.

0 of 1 answered
01How is latent syphilis of unknown duration treated?
Answer every question to submit.
170.05

Protect Brain, Vision, and Hearing Before Damage Becomes Permanent

Neurologic, ocular, and auditory disease can occur at any syphilis stage. Evaluation follows the threatened organ, not the calendar.

What to learn
  • CSF
  • Ophthalmology
  • Otolaryngology
  • IV penicillin
  • Ten to fourteen days
Clinical pathwayProtect brain, vision, and hearing
01SymptomsDefine the state

Connect stage, serology, organ involvement, pregnancy, treatment history, and exposure.

02SpecialistChoose the intervention

Connect stage, serology, organ involvement, pregnancy, treatment history, and exposure.

03CSFCheck the boundary

Connect stage, serology, organ involvement, pregnancy, treatment history, and exposure.

04IV therapyOwn the next decision

Connect stage, serology, organ involvement, pregnancy, treatment history, and exposure.

Use CSF for neurologic findings

Cognitive change, meningitis, stroke, cranial nerve dysfunction, or motor or sensory deficits warrant CSF examination before treatment.

Treat ocular disease urgently

Reactive serology with confirmed ocular abnormalities requires immediate ophthalmology collaboration and neurosyphilis therapy even if CSF is normal.

Do not delay otosyphilis for CSF

Isolated auditory symptoms with a normal neurologic examination rarely gain management value from CSF testing. Coordinate otolaryngology and treat as neurosyphilis.

Use the adult IV regimen

Give aqueous crystalline penicillin G 18 to 24 million units per day as 3 to 4 million units IV every 4 hours or continuous infusion for 10 to 14 days.

0 of 1 answered
01How is confirmed ocular syphilis treated when CSF is normal?
Answer every question to submit.
170.06

Use Penicillin to Treat the Pregnant Patient and the Fetus

Maternal stage, treatment timing, partner treatment, and dose completion determine congenital risk. No nonpenicillin regimen reliably substitutes.

What to learn
  • First prenatal screen
  • Third-trimester retesting
  • Stage therapy
  • Fetal evaluation
  • Delivery documentation
Clinical pathwayTreat two patients
01ScreenDefine the state

Connect stage, serology, organ involvement, pregnancy, treatment history, and exposure.

02StageChoose the intervention

Connect stage, serology, organ involvement, pregnancy, treatment history, and exposure.

03PenicillinCheck the boundary

Connect stage, serology, organ involvement, pregnancy, treatment history, and exposure.

04DeliveryOwn the next decision

Connect stage, serology, organ involvement, pregnancy, treatment history, and exposure.

Screen at the right moments

Screen at the first prenatal visit. Repeat at 28 weeks and delivery for increased geographic or personal risk, and document maternal status before discharge.

Use penicillin only

Treat the maternal stage with penicillin G. If allergy is reported, evaluate and desensitize as needed. Doxycycline and azithromycin do not reliably treat fetal infection.

Add pregnancy-specific safeguards

A second benzathine dose one week after the initial dose can be considered for primary, secondary, or early latent disease. Fetal ultrasound in the second half of pregnancy should not delay treatment.

Protect the weekly sequence

Use an optimal 7-day interval for late latent therapy. If more than 9 days elapse between doses, restart the entire three-dose course.

0 of 1 answered
01What should happen when a pregnant patient with syphilis reports penicillin allergy?
Answer every question to submit.
170.07

Prevent Product, Route, and Allergy Errors

Syphilis therapy is vulnerable to look-alike products, viscous injection challenges, catastrophic route errors, dose-interval loss, and unverified allergy labels.

What to learn
  • Bicillin L-A
  • Not Bicillin C-R
  • Deep IM
  • Never IV
  • Allergy evaluation
Clinical pathwayDeliver the exact product
01L-ADefine the state

Connect stage, serology, organ involvement, pregnancy, treatment history, and exposure.

02DoseChoose the intervention

Connect stage, serology, organ involvement, pregnancy, treatment history, and exposure.

03IntervalCheck the boundary

Connect stage, serology, organ involvement, pregnancy, treatment history, and exposure.

04AllergyOwn the next decision

Connect stage, serology, organ involvement, pregnancy, treatment history, and exposure.

Select the exact product

Use benzathine penicillin G, commonly Bicillin L-A in the United States. Never substitute Bicillin C-R, which combines benzathine and procaine penicillin and does not provide the recommended exposure.

Protect the route

Benzathine penicillin is deep IM only and must never be injected IV. Use an appropriate needle, site, divided injections when needed, and trained technique.

Clarify allergy

Obtain the reaction phenotype and consider skin testing or graded challenge when appropriate. Pregnancy or unreliable alternative follow-up can require desensitization.

Plan for supply constraints

Verify current FDA and public-health product guidance when standard supply is limited, and document the exact product and regulatory pathway used.

0 of 1 answered
01Which medication error can cause syphilis treatment failure?
Answer every question to submit.
170.08

Anticipate the Inflammatory Response Without Calling It Allergy

Spirochete killing can produce fever, chills, myalgia, headache, and transient symptom worsening within 24 hours. It must be separated from anaphylaxis.

What to learn
  • Timing
  • Fever
  • Inflammation
  • Anaphylaxis differential
  • Pregnancy warning
Clinical pathwayAnticipate the treatment response
01CytokinesDefine the state

Connect stage, serology, organ involvement, pregnancy, treatment history, and exposure.

02FeverChoose the intervention

Connect stage, serology, organ involvement, pregnancy, treatment history, and exposure.

03PregnancyCheck the boundary

Connect stage, serology, organ involvement, pregnancy, treatment history, and exposure.

04SupportOwn the next decision

Connect stage, serology, organ involvement, pregnancy, treatment history, and exposure.

Recognize Jarisch-Herxheimer

A cytokine-mediated febrile reaction can begin within hours after treatment, especially in early disease. It is not an IgE-mediated penicillin allergy.

Separate anaphylaxis

Hives, wheeze, angioedema, hypotension, or rapid airway symptoms require emergency anaphylaxis treatment rather than routine supportive care.

Treat supportively

Use fluids and antipyretic or analgesic support as clinically appropriate while monitoring for alternate diagnoses and severe physiology.

Protect pregnancy

After treatment in the second half of pregnancy, fever, contractions, or decreased fetal movement requires urgent obstetric attention. Concern about the reaction must not delay necessary therapy.

0 of 1 answered
01Which finding favors Jarisch-Herxheimer over anaphylaxis?
Answer every question to submit.
170.09

Read Quantitative Change, Not Persistent Positivity

Response monitoring uses the same nontreponemal assay and treatment-day titer. Treponemal tests often remain reactive after cure.

What to learn
  • Same assay
  • Fourfold change
  • Six months
  • Twelve months
  • Twenty-four months
Clinical pathwayRead change, not positivity
01BaselineDefine the state

Connect stage, serology, organ involvement, pregnancy, treatment history, and exposure.

02FourfoldChoose the intervention

Connect stage, serology, organ involvement, pregnancy, treatment history, and exposure.

03TimelineCheck the boundary

Connect stage, serology, organ involvement, pregnancy, treatment history, and exposure.

04ReassessOwn the next decision

Connect stage, serology, organ involvement, pregnancy, treatment history, and exposure.

Calculate fourfold change

A fourfold change equals two dilution steps, such as 1:32 to 1:8. A change from 1:32 to 1:16 is only twofold.

Follow early disease

Primary and secondary syphilis require clinical and serologic evaluation at 6 and 12 months, compared with the titer at treatment.

Follow latent disease

Repeat quantitative nontreponemal testing at 6, 12, and 24 months.

Investigate concerning trends

Persistent or recurrent symptoms or a sustained fourfold rise for more than two weeks suggests reinfection or failure. Reassess exposure, neurologic findings, HIV, treatment, and CSF indications.

0 of 1 answered
01Which RPR change is fourfold?
Answer every question to submit.
170.10

Close Exposure, HIV Risk, and Public Health Together

A successful injection can still leave untreated partners, reinfection, missed HIV prevention, and congenital risk in the community.

What to learn
  • Ninety-day exposure
  • Partner services
  • HIV test
  • PrEP
  • Reporting
Clinical pathwayClose the transmission system
01PartnersDefine the state

Connect stage, serology, organ involvement, pregnancy, treatment history, and exposure.

02HIVChoose the intervention

Connect stage, serology, organ involvement, pregnancy, treatment history, and exposure.

03PrEPCheck the boundary

Connect stage, serology, organ involvement, pregnancy, treatment history, and exposure.

04Public healthOwn the next decision

Connect stage, serology, organ involvement, pregnancy, treatment history, and exposure.

Treat recent exposure presumptively

A partner exposed to primary, secondary, or early latent syphilis within 90 days should receive presumptive early-syphilis treatment even when serology is negative.

Use longer windows for notification

Notify partners from three months plus symptom duration for primary disease, six months plus symptom duration for secondary disease, and one year for early latent disease.

Integrate HIV prevention

Test every patient for HIV. Offer PrEP to appropriate HIV-negative patients and repeat HIV testing when the exposure window or local prevalence supports it.

Remove barriers to closure

Coordinate reporting, partner services, transport, product access, language, housing, privacy, follow-up titers, and abstinence guidance until treatment is complete and partners receive care.

0 of 1 answered
01What should happen after syphilis exposure within 90 days to a partner with primary disease?
Answer every question to submit.

Check the connections.

Each attempt draws 10 questions from the complete 130 question bank.

130 questions in this module bank10 questions per attempt

Each attempt draws a fresh set and rearranges the answer choices.

Current clinical foundation.

Lecture material was synthesized with the following contemporary guidance. Verify local policy and current guidance before applying clinical information.

  1. CDC Syphilis Treatment Guidance
  2. CDC 2024 Syphilis Laboratory Recommendations
  3. CDC Primary and Secondary Syphilis
  4. CDC Latent Syphilis
  5. CDC Neurosyphilis, Ocular Syphilis, and Otosyphilis
  6. CDC Syphilis During Pregnancy
PharmacyOpen tools